Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 3 (2006), Issue 2 (February)

1. Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling.
   J Natl Cancer Inst, 98(3): 203-14. [Abstract] [Full-text]
2. Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies.
   Int J Cancer, 118(4): 970-8. [Abstract] [Full-text]
3. Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers.
   Int J Cancer, 118(4): 797-801. [Abstract] [Full-text]
4. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer.
   Int J Cancer, 118(4): 963-9. [Abstract] [Full-text]
5. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
   Int J Cancer, 118(4): 812-20. [Abstract] [Full-text]
6. Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
   Biochem Biophys Res Commun, 341(3): 856-63. [Abstract] [Full-text]
7. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
   Am J Clin Oncol, 29(1): 21-6. [Abstract] [Full-text]
8. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
   Oncogene, 25(6): 959-68. [Abstract] [Full-text]
9. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
   Oncogene, 25(6): 877-87. [Abstract] [Full-text]
10. Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion.
    Cancer Chemother Pharmacol, 57(5): 584-90. [Abstract] [Full-text]
11. Racial differences in trust and lung cancer patients' perceptions of physician communication.
    J Clin Oncol, 24(6): 904-9. [Abstract] [Full-text]
12. Unpleasant sweet taste: a symptom of SIADH caused by lung cancer.
    J Neurol Neurosurg Psychiatry, 77(3): 405-6. [Abstract] [Full-text]
13. A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma.
    Int J Cancer, 118(8): 1992-7. [Abstract] [Full-text]
14. Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.
    Am J Respir Crit Care Med, 173(5): 535-9. [Abstract] [Full-text]
15. His239Arg SNP of HRAD9 is associated with lung adenocarcinoma.
    Cancer, 106(5): 1117-22. [Abstract] [Full-text]
16. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
    Cancer, 106(5): 1110-6. [Abstract] [Full-text]
17. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Oncogene, 25(8): 1277-80. [Abstract] [Full-text]
18. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    J Am Coll Surg, 202(3): 468-75. [Abstract] [Full-text]
19. Cholinesterase activity of human lung tumours varies according to their histological classification.
    Carcinogenesis, 27(3): 429-36. [Abstract] [Full-text]
20. Sequence specificity of Cr(III)-DNA adduct formation in the p53 gene: NGG sequences are preferential adduct-forming sites.
    Carcinogenesis, 27(3): 639-45. [Abstract] [Full-text]
21. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Carcinogenesis, 27(3): 525-32. [Abstract] [Full-text]
22. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Carcinogenesis, 27(3): 560-7. [Abstract] [Full-text]
23. Enhanced spontaneous metastasis in bikunin-deficient mice.
    Int J Cancer, 118(9): 2322-8. [Abstract] [Full-text]
24. Prevention of mouse lung tumors by targretin.
    Int J Cancer, 118(9): 2359-62. [Abstract] [Full-text]
25. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
    J Clin Oncol, 24(7): 1057-63. [Abstract] [Full-text]
26. Irinotecan in the treatment of small cell lung cancer: a review of patient safety considerations.
    Expert Opin Drug Saf, 5(2): 303-12. [Abstract] [Full-text]
27. Lung cancer risk among former uranium miners of the WISMUT Company in Germany.
    Health Phys, 90(3): 208-16. [Abstract] [Full-text]
28. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
    J Surg Oncol, 93(4): 323-9. [Abstract] [Full-text]
29. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.
    Int J Radiat Oncol Biol Phys, 64(4): 1275-86. [Abstract] [Full-text]
30. Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy.
    Int J Radiat Oncol Biol Phys, 64(4): 1229-36. [Abstract] [Full-text]
31. A technique for adaptive image-guided helical tomotherapy for lung cancer.
    Int J Radiat Oncol Biol Phys, 64(4): 1237-44. [Abstract] [Full-text]
32. Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy.
    Int J Radiat Oncol Biol Phys, 64(4): 1221-8. [Abstract] [Full-text]
33. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
    Int J Radiat Oncol Biol Phys, 64(4): 1100-5. [Abstract] [Full-text]
34. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
    Biochem Biophys Res Commun, 342(2): 655-61. [Abstract] [Full-text]
35. Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells.
    Cancer Immunol Immunother, 55(6): 699-707. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.